Medartis Holding AG

MED

Equity

ISIN CH0386200239 / Valor 38620023

SIX Swiss Exchange (2024-09-18)

CHF 58.30+0.52%

Medartis Holding AG
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Medartis Holding AG is a global leader in the development and manufacturing of implants for osteosynthesis, focusing on cranio-maxillofacial surgery and upper and lower extremities. Their innovative products play a crucial role in the effective treatment of bone fractures, leading to shorter rehabilitation periods and enhanced quality of life for patients.

Summarized from source with an LLMView SourceSector: Healthcare

Revenue Growth

Medartis Holding AG reported a significant increase in total net sales for the first quarter of 2023, reaching CHF 212.0 million. This represents a 20.5% growth compared to the same period in the previous year, driven by strong performance in the EMEA, LATAM, and US regions.

EBITDA Improvement

The underlying EBITDA for Medartis Holding AG surged by 43.4% in Q1 2023, amounting to CHF 33.6 million. This improvement raised the EBITDA margin from 12.8% in 2022 to 15.9% in 2023, indicating enhanced operational efficiency and profitability.

Net Profit

Medartis Holding AG achieved a net profit of CHF 0.6 million in the first quarter of 2023, a notable turnaround from the net loss of CHF 5.8 million reported in the same period of the previous year. This positive result underscores the company's successful financial management and strategic initiatives.

Investment in Growth

During Q1 2023, Medartis Holding AG made significant investments totaling CHF 18.8 million in machinery, consignment sets, and mergers and acquisitions. These investments are aimed at supporting the company's growth and expanding its market presence.

Shareholder Value

Medartis Holding AG's basic earnings per share reached CHF 0.05 in the first quarter of 2023, compared to a loss per share of CHF 0.49 in the previous year. Additionally, the company's share price at year-end stood at CHF 84.0, reflecting increased investor confidence and market valuation.

Summarized from source with an LLMView Source

Key figures

-35.6%1Y

-50.5%3Y

26.7%5Y

Performance

43.4%1Y

45.3%3Y

43.4%5Y

Volatility